Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis;Concentraciones plasmáticas de leptina en los pacientes con cirrosis biliar primaria y su relación con el grado de fibrosis

Gastroenterologia y Hepatologia

Volumn 27, Issue 2, 2004, Pages 47-50

  Garcia Suarez C ^a   Crespo, J ^a   Fernández Gil, P Luis ^a   Amado, J A ^a   Garcia Unzueta M T ^a   Romeroa, F Pons ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; LEPTIN; VIRUS RNA;

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; BLOOD SAMPLING; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CELL INFILTRATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EVALUATION; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LIVER BIOPSY; LIVER FIBROSIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; VENOUS BLOOD;

EID: 10744226713     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056425     Document Type: Article

References (22)

1. Rosnebaum M, Leible RL. The role of leptin in human physiology. N Engl J Med 1999;341:913-5.
2. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70.
3. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130:671-80.
4. Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. Model for the regulation of energy balance and aposity by the central nervous system. Am J Clin Nutr 1999;69:584-96.
5. Van Gaal LF, Wauters MA, Mertens IL, Considine RV, de Leeuw IH. Clinical endocrinology of human leptin. Int J Obes Relat Disord 1999;23(Suppl 1):29-36.
6. Licinio J, Negrao AB, Mantzoros C, Kaklamani V, Wong ML, Bongiorno PB, et al. Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab 1998;83:4140-7.
7. Kokot F, Adamczak M, Wiecedilek A, Spiechowicz U, Mesjasz J. Plasma immunoreactive leptin and neuropeptide Y levels in kidney transplant patients. Am J Nephrol 1999;19:28-33.
8. Kagan A, Haran N, Leschinsky L, Shuali N, Rapoport J. Leptin in CAPD patients: serum concentrations and peritoneal loss. Nephrol Dial Trasplant 1999;14:400-5.
9. Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology 1999;29:1818-24.
10. Crespo J, Rivero M, Fábrega E, Cayón A, Amado JA, García Unzueta MT, et al. Plasma leptin and TNF-alpha levels en chronic hepatitis C patients and their relationship to the fibrosis. Dig Dis Sci 2002;47:1604-10.
11. Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, et al. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 1999;46:2422-5.
12. Testa R, Franceschini R, Giannini E, Cataldi A, Fasoli A, Tenerelli P, et al. Serum leptin levels in patients with viral chronic hepatitis or liver cirrosis. J Hepatol 2000;33:33-7.
13. Ikejima K, Honda H, Takei Y. Hepatic stellare cells produce leptin during the progression of liver fibrosis. Hepatology 1999;30(Suppl 1):492.
14. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002;35:762-71.
15. Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic cells results in leptin expression. Biochem Biophys Res Commun 1998;244:178-82.
16. Cayón A, Crespo J, Guerra A, Orive A, Cuadrado A, Pons-Romero F. Cytokine expression profile in the nonalcoholic steatohepatitis patients. The 38th Annual Meeting of European Association for the Study of the Liver (EASL); 2003, July 3-6; Geneve. Geneve: EASL, 2003.
17. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, et al. Transdifferetiation of rat hepatic cells leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001;34:288-97.
18. Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exrted by tumor necrosis factor. J Exp Med 1999;189:207-12.
19. Francis J, Mohankumar PS, Mohankumar SM, Quadri SK. Systemic administration of lipopolysacharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor. Endocrine 1999;10:291-5.
20. Santos-Alvarez J, Goberna R, Sánchez Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999;194:6-11.
21. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56:860-72.
22. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signalling regulates fibrogenesis and remodelling of extracellular matrix in the rat. Gastroenterology 2002;122:1399-410.